Skip to main content


Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
2019 ESC/EAS Guidelines for the Management of Dyslipidaemias

Jan 1, 2020/CPG

Address the management of dyslipidaemias as an essential and integral part of cardiovascular disease (CVD) prevention.

Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management, 8th Edition, Version 2

Aug 1, 2017/CPG

Guidelines to support effective assessment and treatment that focus more on actively managing pain based on function and assisting patients to reach their goals.

Risk Assessment Prediction Tool (RAPT)

May 23, 2017/Test & Measure

Risk Assessment Prediction Tool (RAPT)


Jun 28, 2017/Test & Measure

Used during systems review to identify cognitive impairment in various patient populations.

Physical Activity Readiness Questionnaire (PAR-Q, PAR-Q+)

Aug 14, 2017/Test & Measure

The PAR-Q was developed in an effort to standardize activity screening for persons aged 15-69 years.

2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary

Nov 13, 2016/CPG

Guideline for diagnosis and management of patients with lower extremity peripheral artery disease (PAD) and addresses disease of the aortoiliac, femoropopliteal, and infrapopliteal arterial segments.

Global Deterioration Scale for Assessment of Primary Degenerative Dementia (GDS)

Aug 22, 2017/Test & Measure

A quick screening tool to detect the early onset of dementia as well as the severity of the condition.

Pain Stages of Change Questionnaire (PSOCQ)

Aug 14, 2017/Test & Measure

This tool is used to assess adults and adolescents who have chronic pain.

Diagnosis and Treatment of Ischemic Stroke: Twelfth Edition

Jun 1, 2019/CPG

Recommendations for early management of stroke due to ischemic brain ischemia/infarction and emphasizes the importance of getting appropriate early care for persons with an onset of stroke symptoms.

Cerebral Palsy in Under 25s [NICE NG62]

Jan 25, 2017/CPG

Guidelines to ensure proper care for the developmental and clinical comorbidities associated with cerebral palsy for those under 25 years old to ensure they can be active and independent.